title: Iron supplementation in adolescent hemodialysis patients.
abstract: OBJECTIVE
  Iron supplementation is necessary in children on hemodialysis, but the optimal protocol remains unknown. We studied the effects of changing our unit's protocol from oral iron with periodic doses of parenteral iron dextran to routine administration of parenteral sodium ferric gluconate on anemia and iron parameters.
  
  
  METHODS
  We followed seven hemodialysis patients aged 15 20 years (mean 17 years). Hemoglobin, hematocrit, serum iron, transferrin saturation, ferritin, erythropoietin dose, total elemental iron dose and total iron cost for the six months prior to the protocol change were compared to the same variables during the six months following the change.
  
  
  RESULTS
  There was no statistically significant difference between the doses of parenteral iron between the two protocols; however, the total dose of elemental iron administered in the oral iron plus iron dextran protocol was greater than in the sodium ferric gluconate protocol (19.6+/-13.1 (mean+/-SD) mg/kg/week versus 1.1+/-0.3 mg/kg/week; p = 0.03). Both protocols had equivalent efficacy with respect to hemoglobin, ferritin and other measures of iron stores. On the other hand, the costs of sodium ferric gluconate were significantly higher than those of oral iron plus intermittent iron dextran (157.75+/-45.94 $/patient/month versus 52.08+/-49.88 $/patient/month; p = 0.01).
  
  
  CONCLUSIONS
  Routine administration of sodium ferric gluconate is equivalent if not superior to use of oral iron plus iron dextran for maintenance of iron stores in adolescents on hemodialysis, but more expensive.
authors.affiliation: Division of Pediatric Nephrology, Children's Hospital at Montefiore, Bronx, New York 10467, USA.
authors.forename: C
authors.initials: C
authors.lastname: Nailescu
authors.forename: M
authors.initials: M
authors.lastname: Castaneda
authors.forename: M
authors.initials: M
authors.lastname: Del Rio
authors.forename: J T
authors.initials: JT
authors.lastname: Flynn
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage*; D005293:Ferritins / Q000097:blood; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000008:administration & dosage* / Q000097:blood; D007505:Iron-Dextran Complex / Q000008:administration & dosage*; D008297:Male; D010288:Parenteral Nutrition; D006435:Renal Dialysis; D014168:Transferrin / Q000378:metabolism
chemical_list: D005290:Ferric Compounds; D006454:Hemoglobins; D014168:Transferrin; D007505:Iron-Dextran Complex; D005293:Ferritins; D007501:Iron; C035552:ferric gluconate